2 results match your criteria: "University of Texas MD Anderson Cancer Center and McGovern Medical School at Houston[Affiliation]"
Sex Med Rev
March 2025
Department of Urology, University of Texas MD Anderson Cancer Center and McGovern Medical School at Houston, Houston, 77030, TX, United States.
Introduction: Penile prosthesis (PP) is one of the main approved therapies for erectile dysfunction (ED). Greater than 50 years of clinical use has led to considerable innovation in PP surgery and patient care.
Objectives: To summarize the current literature and provide updated clinical evidence to inform healthcare providers on best practices with PP.
Sex Med Rev
February 2025
Department of Urology, Mayo Clinic, Rochester, MN 55905, United States.
Introduction: Vacuum erectile device (VED) is 1 of the main approved therapies for erectile dysfunction (ED). The introduction of phosphodiesterase type 5 inhibitor (PDE5i) for ED significantly changed the roles of VED in contemporary sexual medicine.
Objective: To provide updated clinical evidence to inform health care providers on best practices with VED.